MARKET SURGERY — All Prescriptions & Medications — Page 12
Practice Code: D82016 | NORWICH, NR11 6BW
Showing results 551-600 of 629
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Permethrin | 14 | 810 | £223 | -62.8% ▼ |
| 14 | 596 | £98 | -53.1% ▼ | |
| 14 | 1,400 | £2.8K | -71.3% ▼ | |
| 14 | 780 | £1.2K | -20.6% ▼ | |
| 14 | 39 | £492 | +37.3% ▲ | |
| 14 | 140 | £51 | +8.4% ▲ | |
| 14 | 460 | £3.2K | +10.4% ▲ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 13 | 364 | £42 | -62.6% ▼ |
| Celiprolol hydrochloride | 13 | 364 | £243 | -1.7% vs avg |
| Irbesartan with diuretic | 13 | 364 | £73 | -17.4% ▼ |
| Losartan potassium with diuretic | 13 | 364 | £79 | -49.3% ▼ |
| Acipimox | 13 | 782 | £358 | +45.5% ▲ |
| Lormetazepam | 13 | 390 | £144 | +10.4% ▲ |
| Levomepromazine maleate | 13 | 266 | £319 | +41.6% ▲ |
| Riluzole | 13 | 3,992 | £3.1K | +25.3% ▲ |
| Metformin hydrochloride/sitagliptin | 13 | 728 | £411 | -65.3% ▼ |
| Dexamethasone phosphate | 13 | 150 | £212 | +185.0% ▲ |
| Cabergoline | 13 | 104 | £174 | -16.2% ▼ |
| Fluorouracil (Antimetabolites) | 13 | 260 | £345 | +285.6% ▲ |
| Magnesium glycerophosphate | 13 | 780 | £899 | -5.4% ▼ |
| Hydrocort sodiumphos | 13 | 390 | £127 | +69.8% ▲ |
| Tafluprost and timolol | 13 | 390 | £168 | -32.3% ▼ |
| Sodium chloride | 13 | 731 | £347 | +96.4% ▲ |
| Ivermectin | 13 | 615 | £344 | -38.9% ▼ |
| Lidocaine | 13 | 580 | £89 | +13.1% ▲ |
| 13 | 230 | £796 | -38.5% ▼ | |
| 13 | 13 | £14 | -50.8% ▼ | |
| 13 | 29 | £278 | +9.2% ▲ | |
| 13 | 150 | £381 | +10.5% ▲ | |
| 13 | 360 | £1.9K | -41.7% ▼ | |
| 13 | 370 | £2.4K | +1.8% vs avg | |
| Methyldopa | 12 | 1,344 | £327 | -29.5% ▼ |
| INR blood testing reagents | 12 | 288 | £814 | +59.3% ▲ |
| Dabigatran etexilate | 12 | 720 | £507 | -76.8% ▼ |
| Insulin glulisine | 12 | 125 | £708 | -44.0% ▼ |
| Bromocriptine | 12 | 360 | £737 | +80.9% ▲ |
| Triptorelin acetate | 12 | 12 | £736 | -16.3% ▼ |
| Imiquimod | 12 | 348 | £1.4K | +68.9% ▲ |
| Hepatitis B | 12 | 12 | £139 | +13.4% ▲ |
| 12 | 2,160 | £3.2K | +22.7% ▲ | |
| 12 | 1,080 | £1.8K | -43.3% ▼ | |
| 12 | 220 | £103 | -46.3% ▼ | |
| 12 | 112 | £121 | -11.7% ▼ | |
| 12 | 560 | £410 | -9.6% ▼ | |
| 12 | 560 | £396 | -63.7% ▼ | |
| Olmesartan medoxomil/amlodipine | 11 | 308 | £177 | -16.6% ▼ |
| Gemfibrozil | 11 | 308 | £174 | +8.9% ▲ |
| Zonisamide | 11 | 616 | £267 | -74.8% ▼ |
| Ethosuximide | 11 | 1,540 | £3.1K | -25.4% ▼ |
| Midazolam maleate | 11 | 22 | £986 | +128.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.